Burden of liver cancer resulting from different etiologies in China from 1990 to 2021 and prediction to 2031
PLOS One · 2025
DOI: 10.1371/journal.pone.0338908 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Meiling Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Zhongshan Hospital Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China. Hauptthemen laut MEDLINE: Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Liver cancer (LC) imposes a considerable disease burden in China, with diverse causes contributing to varying proportions of LC cases. Adjusting future public health strategies for the allocation of resources to interventions aimed at different causes of LC is a subject that demands resolution in order to maximize health benefits. Employing the Global Burden of Disease (GBD) 2021, we analyzed the burden of LC in China attributed to different causes. Utilize joinpoint to evaluate the trend of the disease burden of LC. The Bayesian model for age-period-cohort (BAPC) was adopted to forecast the burden. The overall trend of the age-standardized rates of incidence, mortality, and disability-standardized life years (ASIR, ASMR, and ASDR) of LC were descend in China from 1990 to 2021. HBV, HCV, alcohol and non-alcoholic steatohepatitis (NASH) constitute the four principal causes of the LC burden. The ASIR, ASMR, and ASDR of LC caused by HBV and HCV showed a downward trend. The ASIR of LC caused by alcohol and NASH were associated with an increased. It was anticipated that the burden of ASIR and ASMR for male, female, and the entire population in China will persistently decline until 2031. In conclusion, the burden of LC has displayed a downward trend in China from 1990 to 2021; HBV, HCV, alcohol, and NASH were the main causes of LC; the burden of LC is expected to further decline by 2031.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Infectious Diseases, Zhongshan Hospital Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.
- Department of Nephrology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.
ORCID-Profile: Siyang Huang
Zitieren
APA
Zhang, M., Tan, Y., Fang, Z., Li, F., Chen, X., Chen, X., Deng, Y., & Huang, S. (2025). Burden of liver cancer resulting from different etiologies in China from 1990 to 2021 and prediction to 2031. PLOS One. https://doi.org/10.1371/journal.pone.0338908
Vancouver
Zhang M, Tan Y, Fang Z, Li F, Chen X, Chen X, et al. Burden of liver cancer resulting from different etiologies in China from 1990 to 2021 and prediction to 2031. PLOS One. 2025. doi:10.1371/journal.pone.0338908
BibTeX
@article{Zhang2025,
author = {Zhang, Meiling and Tan, Yan and Fang, Zegui and Li, Feng and Chen, Xiaoxiao and Chen, Xiaoshan and Deng, Yongyue and Huang, Siyang},
title = {Burden of liver cancer resulting from different etiologies in China from 1990 to 2021 and prediction to 2031},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0338908}
}
EUVIMED